KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
U.S. stocks traded lower, with the Dow Jones gaining more than 100 points on Friday. Here are some big stocks recording gains in today’s session. Gravitas Education Holdings, Inc. (NASDAQ: GEHI) sh

US Stocks Open Lower; Dow Drops Over 100 Points

02:59pm, Friday, 14'th Oct 2022 Benzinga
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Friday. Following the market opening Friday, the Dow traded down 0.37% to 29,927.92 while the NASDAQ fell 1.4
On a sharply down day at the tail end of the week, Reata Pharmaceuticals (NASDAQ: RETA ) provided a dramatic counterpoint. While the benchmark S&P 500 index slipped near 2% down, RETA stock gained ove

Reata Pharma (RETA) is Striving Hard Despite Pipeline Setbacks

12:58pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
Reata Pharmaceuticals (RETA) is yet to generate product revenues due to the lack of marketed drugs in its portfolio. However, two of its pipeline candidates are close to potential FDA approval.
Reata Pharmaceuticals (RETA) is yet to generate product revenues due to the lack of marketed drugs in its portfolio. However, two of its pipeline candidates are close to potential FDA approval.

Why Is Kodiak Sciences Inc. (KOD) Down 23.8% Since Last Earnings Report?

03:30pm, Thursday, 08'th Sep 2022 Zacks Investment Research
Kodiak Sciences Inc. (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Gainers IMARA Inc. (NASDAQ: IMRA) jumped 74.8% to settle at $2.01 on Wednesday after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontr

Reata Pharmaceuticals, Inc. (RETA) Up 4.7% Since Last Earnings Report: Can It Continue?

03:30pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Reata Pharmaceuticals, Inc. (RETA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Baird has decided to maintain its Neutral rating of Reata Pharmaceuticals (NASDAQ:RETA) and lower its price target from $37.00 to $27.00. Shares of Reata Pharmaceuticals are trading down 8.1% over the

Reata (RETA) Q2 Earnings Miss, Revenues Down Y/Y, Stock Down

03:56pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Reata (RETA) reports a wider-than-expected loss in the second quarter of 2022, while revenues miss estimates. Stock falls after updates on pipeline programs.
Reata (RETA) reports a wider-than-expected loss in the second quarter of 2022, while revenues miss estimates. Stock falls after updates on pipeline programs.
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday. TOP Financial Group Limited (NASDAQ: TOP) jumped 102.7% to settle at $20.57 after gain

Nasdaq Turns Lower; Crude Oil Rises Over 1%

06:38pm, Monday, 08'th Aug 2022 Benzinga
U.S. stocks pared gains toward the end of trading, with the S&P 500 and the Nasdaq turning lower on Monday. The Dow traded up 0.13% to 32,845.34 while the NASDAQ fell 0.20% to 12,631.80. The S&P also
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6
U.S. stocks traded higher this morning, following the release of strong jobs data on Friday. The Dow traded up 0.50% to 32,965.86 while the NASDAQ rose 0.67% to 12,742.92. The S&P also rose, gaining,
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE